Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

9,793 public trials 1,785 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Active, not recruiting

Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making

NCT03766009

Conditions
Breast Cancer Stage 0, Breast Cancer Stage I, Breast Cancer Stage II, +12 more
Locations
  • Epic Care-Dublin Dublin, California, United States
  • Bay Area Breast Surgeons Inc Emeryville, California, United States
  • Epic Care Partners in Cancer Care Emeryville, California, United States
  • Contra Costa Regional Medical Center Martinez, California, United States
View all 58 locations
View Trial Details
Active, not recruiting

Onvansertib + Paclitaxel In TNBC

NCT05383196

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +15 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Beth Israel Deaconness Medical Center Boston, Massachusetts, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Active, not recruiting

TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)

NCT05548127

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • Stanford Women's Cancer Center Palo Alto, California, United States
  • UCSF Medical Center at Mission Bay San Francisco, California, United States
  • Moffitt Cancer Center - International Plaza Tampa, Florida, United States
  • Moffitt Cancer Center, Richard M. Shulze Family Foundation Outpatient Center Tampa, Florida, United States
View all 39 locations
View Trial Details
Active, not recruiting

Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer

NCT05909397

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
Locations
  • BRCR Global Plantation, Florida, United States
  • BRCR Medical Center Inc Plantation, Florida, United States
  • Virginia Oncology Associates Norfolk, Virginia, United States
  • Cancer Research SA Adelaide, South Australia, Australia
View all 29 locations
View Trial Details
Active, not recruiting

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

NCT01674140

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 1459 locations
View Trial Details
Active, not recruiting

Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1)

NCT05501886

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Arizona Oncology (US Oncology/McKesson) - Goodyear Goodyear, Arizona, United States
  • St. Bernards Medical Center Jonesboro, Arkansas, United States
  • CARTI Cancer Center Little Rock, Arkansas, United States
View all 235 locations
View Trial Details
Active, not recruiting

P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors

NCT05239143

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Cancer, +66 more
Locations
  • University of California, Irvine Medical Center Irvine, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
View all 14 locations
View Trial Details
Active, not recruiting

Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer

NCT02308085

Conditions
Breast Diseases, Breast Neoplasms, Early Breast Cancer, +4 more
Locations
  • Cedars Sinai Medical Centre Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • Sharp Memorial Hospital San Diego, California, United States
  • University of Colorado Cancer Centre - Anschutz Cancer Pavilion Aurora, Colorado, United States
View all 211 locations
View Trial Details
Active, not recruiting

A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

NCT04478279

Conditions
Astrocytoma, Brain Cancer, Brain Diseases, +43 more
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Sarah Cannon Research Institute Denver, Colorado, United States
  • Northwestern Medicine Cancer Centers Warrenville, Illinois, United States
  • START Midwest Grand Rapids, Michigan, United States
View Trial Details
Active, not recruiting

Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)

NCT04639986

Conditions
Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
Locations
  • Cancer Hospital Chinese Academy of Medical Science Beijing, China
  • Chinese PLA General Hospital Beijing, China
  • Peking University People's Hospital Beijing, China
  • Jilin Cancer Hospital Changchun, China
View all 43 locations
View Trial Details

Related conditions